10:12 WANJI PHARMA<00835> - Announcement (4) Islands which in turn is interested in approximately 51% of the entire issued share capital of the Company. IMPLICATIONS UNDER THE LISTING RULES The Options to be granted to Mr. Yen and Mr. Lam represent approximately 4% and 2% of the total issued share capital of the Company respectively as at the date of this announcement. In accordance with the note to rule 17.03(4) of the Listing Rules, as the grant of the Options to Mr. Yen and Mr. Lam would result in the Shares to be issued upon exercise of all options granted and to be granted to each of Mr. Yen and Mr. Lam in the 12-month period up to and including the date of such grant representing in aggregate over 1% of the total issued share capital of the Company, the grant of the Options must be approved by the Shareholders by way of poll in general meeting with Mr. Yen and Mr. Lam and their respective associates abstaining from voting. GENERAL The Directors (including the independent non-executive Directors) consider that the terms of the Options are fair and reasonable. A circular containing, among other things, further details and terms in respect of the grant of the Options, the recommendation of the Independent Board Committee to the Independent Shareholders on the grant of the Options to Mr. Yen and Mr. Lam together with a notice of special general meeting will be despatched to the Shareholders as soon as possible. DEFINITIONS In this announcement, unless the context otherwise requires, the following expressions shall have the following meaning: "associates" has the meaning ascribed to this term under the Listing Rules "Board" board of directors of the Company "Company" Wanji Pharmaceutical Holdings Limited, a company incorporated in Bermuda with limited liability and the issued Shares of which are listed on the main board of the Stock Exchange "connected person" has the meaning ascribed to this term under the Listing Rules "Director(s)" director(s) of the Company "Group" the Company and its subsidiaries "Hong Kong" the Hong Kong Special Administrative Region of the PRC "Independent Board an independent board committee, comprising Mr. Li Ka Committee" Fai, David, Mr. Tang Shun Lam and Mr. Yung Ha Kuk, Victor to advise the Independent Shareholders as to the fairness and reasonableness of the grant of the Options "Independent Shareholders other than Mr. Yen, Mr. Lam and their Shareholders" respective associates "Listing Rules" the Rules Governing the Listing of Securities on the Stock Exchange "Mr. Lam" Mr. Lam Wai Hung, Freddie, the chief operation officer of the Group